S 2723
116th Congress
Senate
Health
Business records
Congressional oversight
Consumer affairs
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health care coverage and access
Health information and medical records
Health technology, devices, supplies
Manufacturing
Prescription drugs
Public-private cooperation
Mitigating Emergency Drug Shortages Act
Introduced: October 29, 2019
Introduced by:
Collins, Susan M.
Republican
· Maine
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 29, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
Oct 29, 2019
Introduced in Senate
Plain-English summary
Mitigating Emergency Drug Shortages Act
This bill requires the Food and Drug Administration (FDA) to prioritize the review of life-saving or life-sustaining drugs that are facing shortages. The bill also requires manufacturers to report certain information to the FDA when there is a permanent discontinuance or interruption in the manufacture of active pharmaceutical ingredients for such drugs.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
Committees of jurisdiction
1